A University of Iowa-led team of researchers has used the gene editing method called CRISPR-Cas9 to disrupt a mutant gene that is responsible for some forms of glaucoma, one of the most common causes of irreversible blindness.
Oct 2, 2017
0
51
In mice genetically predisposed to glaucoma, vitamin B3 added to drinking water is effective at preventing the disease, a research team led by Jackson Laboratory Professor and Howard Hughes Medical Investigator Simon W.M. ...
Feb 16, 2017
0
211
Scientists at the University of California, San Diego School of Medicine have elucidated a genetic interaction that may prove key to the development and progression of glaucoma, a blinding neurodegenerative disease that affects ...
Sep 10, 2015
0
35
Researchers at the University of California, San Diego School of Medicine and Sun Yat-sen University in China have shown that acute glaucoma in mice is largely an inflammatory disease and that high pressure in the eye causes ...
Jul 14, 2014
0
0
High intraocular pressure (IOP) is a significant risk factor for glaucoma. Current IOP tests are mostly conducted in hospitals, while portable home tonometers that provide convenient IOP monitoring are expensive and often ...
Apr 3, 2024
0
0
There is an adverse association between calcium channel blocker (CCB) use and glaucoma, according to a study published online Sept. 7 in JAMA Ophthalmology.
Sep 9, 2023
0
14
The U.S. Food and Drug Administration has approved Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy secondary to age-related macular degeneration.
Aug 10, 2023
0
2
An international team of researchers led by Lithuanian scientists provide additional evidence that intracranial pressure plays an important role in normal-tension glaucoma, which accounts for up to 50 percent of all glaucoma ...
Feb 13, 2023
0
68
A comprehensive eye exam could be the key to determining if you have glaucoma, a silent thief of sight.
Jan 4, 2023
0
15
Glaucoma is the leading cause of irreversible blindness due to optic nerve damage and the death of retinal ganglion cells (RGCs). Presently, reducing intraocular pressure is the sole evidence-based therapy for glaucoma patients, ...
Dec 20, 2022
0
45
